TrialPath

17 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Multiple sclerosis (MS)

    📍 Georgia State University · Atlanta, GA · +1 more US site · Get directions →

    The purpose of this study is to test if ublituximab changes walking functions and fall risk in people with relapsing multiple sclerosis (RMS). Twenty-five qualified people with RMS will undergo a 48-week ublituximab treatment.

    ✓ Study care freeEarly Phase 1Ages 18–55Learn more →
  • Asthma

    📍 Oklahoma Children's Hospital · Oklahoma City, OK · Get directions →

    This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

    ✓ Study care freeEarly Phase 1Ages 5–17Learn more →
  • Depression

    📍 UCSF · San Francisco, CA · Get directions →

    This double-blind, placebo-controlled clinical trial will examine the effect of probiotic Visbiome on the brain and gut microbiome of individuals 15 to 24 years of age.

    ✓ Study care freeEarly Phase 1Ages 15–24Learn more →
  • Depression

    📍 University of Chicago · Chicago, IL · Get directions →

    This study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological marker.

    ✓ Study care freeEarly Phase 1Ages 18–40Learn more →
  • Depression

    📍 Emory University · Atlanta, GA · Get directions →

    The main purpose of this study is to investigate the effects of ketamine on decision-making and emotion processing in a sample of individuals diagnosed with Major Depressive Disorder (MDD).

    ✓ Study care freeEarly Phase 1Ages 18–65Learn more →
  • Depression

    📍 UCLA Semel Institute - Neuropsychiatric Institute (NPI) · Los Angeles, CA · Get directions →

    Osteoarthritis (OA) is a major public health problem, and involvement of the knee is especially disabling. Symptomatic knee OA has an incidence rate between 40 to 1,020 per 100,000 person years1 and is among the most common causes of disability worldwide.

    ✓ Study care freeEarly Phase 1Ages 50–95Learn more →
  • Depression

    📍 McLean Hospital · Belmont, MA · Get directions →

    Many people with depression do not get better with standard treatments like medication. One promising alternative is transcranial magnetic stimulation (TMS), a non-invasive procedure that uses magnetic pulses to stimulate specific brain regions.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • Depression

    📍 Institute for Mental Health Research · Austin, TX · Get directions →

    The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are: * Aim 1:examine whether gamified ABM leads to greater change in the primary and secondary outcomes than sham ABM * Aim 1: establish that gamified ABM is at least as effective as traditional ABM.

    ✓ Study care freeEarly Phase 1Ages 18–70Learn more →
  • Depression

    📍 University of Pennsylvania · Philadelphia, PA · Get directions →

    In the treatment of Major Depressive Disorder (MDD), ketamine can produce rapid but short-lasting improvements in mood. In order to develop a new generation of treatments with rapid and sustained efficacy, a better understanding of the mechanism of action is urgently needed.

    ✓ Study care freeEarly Phase 1Ages 25–65Learn more →
  • DepressionDementia / Alzheimer's

    📍 Johns Hopkins Center for Psychedelic and Consciousness Research · Baltimore, MD · Get directions →

    This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve quality of life in those individuals.

    ✓ Study care freeEarly Phase 1Ages 18–85Learn more →
  • Multiple sclerosis (MS)

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    The investigators propose to use the novel SV2a-PET ligand, \[F-18\]SDM-8 to assess synaptic density in progressive multiple sclerosis (PMS) (including primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS)), given its improved imaging characteristics and potential for large scale applicability. The specific aims of the study are: Aim 1: To compare the cortical and subcortical grey matter synaptic density in PMS patients, patients with relapsing-remitting MS (RRMS), and healthy subjects, using a novel \[F-18\] labeled synaptic density PET ligand, \[F-18\]SDM8, also known as \[F-18\]SynvesT-1.

    ✓ Study care freeEarly Phase 1Ages 18–60Learn more →
  • Multiple sclerosis (MS)

    📍 Brain Health Alliance · Ladera Ranch, CA · Get directions →

    To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

    ✓ Study care freeEarly Phase 1Ages 25–55Learn more →
  • Crohn's / ulcerative colitis (IBD)

    📍 Mayo Clinic · Rochester, MN · Get directions →

    This study is a prospective, case-control study evaluating whether the PET radiotracer 68Ga-FAPI-46 can detect fibrostenosing Crohn's disease in the small bowel. The goal is to determine whether areas of early or developing fibrosis ("pre-stricture" changes) demonstrate uptake of the tracer, which binds to fibroblast activation protein (FAP).

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • Crohn's / ulcerative colitis (IBD)

    📍 Stanford University · Stanford, CA · Get directions →

    The goal of this clinical trial is to learn if statins work to prevent strictures in adults with Crohn's disease. The main question it aims to answer is: * Can statins reduce the formation of strictures in participants with stricturing Crohn's disease?

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Crohn's / ulcerative colitis (IBD)

    📍 Stanford University · Stanford, CA · Get directions →

    PSC is a liver disease that has no medical cure. Patients with PSC are at a greatly increased risk of cancer and infection.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Crohn's / ulcerative colitis (IBD)

    📍 UMASS medical center · Worcester, MA · Get directions →

    This study is investigating whether a cranberry-based dietary supplement, rich in polyphenols and fiber, can enhance gut health in individuals with Crohn's disease. People with Crohn's disease often have an imbalance in their gut microbiome (the community of bacteria in the gut).

    ✓ Study care freeEarly Phase 1Ages 18–65Learn more →
  • DepressionAnxiety

    📍 Aqqiumavvik Society · Arviat, Nunavut · Get directions →

    This study is looking at how eating more country foods affects mental health among Inuit men and women in Arviat, NU. The goal is to evaluate if eating more of these foods helps people feel less depressed or anxious, and whether being part of food-gathering and cultural activities also makes a difference.

    ✓ Study care freeEarly Phase 1Ages 18–65Learn more →